X-5892984-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_181332.3(NLGN4X):āc.2284C>Gā(p.Leu762Val) variant causes a missense change. The variant allele was found at a frequency of 0.00000496 in 1,209,649 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Genomes: š 0.000027 ( 0 hom., 0 hem., cov: 22)
Exomes š: 0.0000027 ( 0 hom. 2 hem. )
Consequence
NLGN4X
NM_181332.3 missense
NM_181332.3 missense
Scores
2
5
10
Clinical Significance
Conservation
PhyloP100: 6.68
Genes affected
NLGN4X (HGNC:14287): (neuroligin 4 X-linked) This gene encodes a member of the type-B carboxylesterase/lipase protein family. The encoded protein belongs to a family of neuronal cell surface proteins. Members of this family may act as splice site-specific ligands for beta-neurexins and may be involved in the formation and remodeling of central nervous system synapses. The encoded protein interacts with discs large homolog 4 (DLG4). Mutations in this gene have been associated with autism and Asperger syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.33060098).
BS2
High Hemizygotes in GnomAdExome4 at 2 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NLGN4X | NM_181332.3 | c.2284C>G | p.Leu762Val | missense_variant | 6/6 | ENST00000381095.8 | NP_851849.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NLGN4X | ENST00000381095.8 | c.2284C>G | p.Leu762Val | missense_variant | 6/6 | 1 | NM_181332.3 | ENSP00000370485 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000269 AC: 3AN: 111381Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33543
GnomAD3 genomes
AF:
AC:
3
AN:
111381
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33543
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 183520Hom.: 0 AF XY: 0.0000147 AC XY: 1AN XY: 67952
GnomAD3 exomes
AF:
AC:
2
AN:
183520
Hom.:
AF XY:
AC XY:
1
AN XY:
67952
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000273 AC: 3AN: 1098268Hom.: 0 Cov.: 32 AF XY: 0.00000550 AC XY: 2AN XY: 363622
GnomAD4 exome
AF:
AC:
3
AN:
1098268
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
363622
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000269 AC: 3AN: 111381Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33543
GnomAD4 genome
AF:
AC:
3
AN:
111381
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33543
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 20, 2018 | The p.L762V variant (also known as c.2284C>G), located in coding exon 5 of the NLGN4X gene, results from a C to G substitution at nucleotide position 2284. The leucine at codon 762 is replaced by valine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Intellectual disability Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Human Genetics Laboratory, State University of Rio de Janeiro | Oct 07, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;T;.;T
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
.;D;.;D;.
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;M;.;M
MutationTaster
Benign
D;D;D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;.;N;.;N
REVEL
Benign
Sift
Uncertain
D;.;D;.;D
Sift4G
Uncertain
D;D;D;.;D
Polyphen
D;D;D;D;D
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at